Neil Stevens, PHI Managing Director, went recently to the AASLD conference in Washington DC. We asked him why he went, what he learnt and what happens now.
hepatoSIGHT™ achieves CE marking, paving the way for use across Europe
(London, UK) 10 September 2024. Following our recent announcement that hepatoSIGHT has received MHRA UKCA marking, we are excited to share that hepatoSIGHT has now also